West Pharmaceutical Services, Inc. (WST)

NYSE: WST · Real-Time Price · USD

270.60

+3.41 (1.28%)

At close: Oct 17, 2025, 4:00 PM EDT

275.38

+4.78 (1.77%)

After-hours: Oct 17, 2025, 7:58 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Proprietary Products Revenue	2.40B	2.33B	Log In	Log In	Log In	Upgrade
Contract-Manufactured Products Revenue	562.10M	558.70M	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.96B	2.89B	Log In	Log In	Log In	Upgrade

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Proprietary Products Operating Profit	612.80M	577.80M	Log In	Log In	Log In	Upgrade
Contract-Manufactured Products Operating Profit	69.30M	72.30M	Log In	Log In	Log In	Upgrade
Operating Income (Other)	-100.50M	-80.20M	Log In	Log In	Log In	Upgrade
Operating Income (Total)	581.60M	569.90M	Log In	Log In	Log In	Upgrade

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Organic Net Sales Growth	-	-1.50%	Log In	Log In	Log In	Upgrade

Updated Jul 24, 2025. Data Source: Fiscal.ai.